Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-12-000045
Filing Date
2012-01-05
Accepted
2012-01-05 18:17:00
Documents
1
Period of Report
2012-01-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT c68035_form4.html 4  
1 OWNERSHIP DOCUMENT c68035_form4.xml 4 4154
  Complete submission text file 0000930413-12-000045.txt   5895
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENZON PHARMACEUITCALS, INC. 685 ROUTE 202/206 BRIDGEWATER NJ 08807
Business Address
Young Richard A (Reporting) CIK: 0001490283 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 12512525